Opportunity Information: Apply for CDC RFA GH19 1967
This funding opportunity (CDC RFA GH19-1967) is a discretionary cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Center for Global Health. It is designed to renew and extend a long-running CDC partnership with the World Health Organization (WHO) that has operated as a broad umbrella for collaborative work on emerging and epidemic-prone infectious diseases. The specific context is that CDC and WHO entered a five-year cooperative agreement beginning September 1, 2015, scheduled to end August 31, 2019, and this announcement is intended to continue that relationship beyond the current project period. While CDC and WHO have worked together through similar agreements since 1995, this FOA formalizes the next phase of collaboration with clearer institutional direction and priorities.
A central driver behind the work is the 2011 Memorandum of Understanding (MOU) between the U.S. Government and WHO, which focuses on helping WHO Member States strengthen their ability to meet the requirements of the International Health Regulations (2005). The IHR (2005) set expectations for countries to build core capacities to detect, assess, report, and respond to public health threats that can cross borders. The FOA emphasizes that prior CDC-WHO cooperative agreement activities have already supported the MOU goals by improving infectious disease surveillance and response systems, strengthening national public health infrastructure, and providing technical assistance that contributes to global health security. This renewed funding opportunity is positioned as a continuation of that same mission, with an emphasis on practical country capacity building and coordinated outbreak readiness and response.
The FOA is structured around two main components. Component 1, described as "Core Activities," covers the ongoing backbone of CDC and WHO collaboration, largely implemented through WHO programs now housed within the WHO Health Emergencies Program (WHE). This component reflects decades of joint work worldwide to prevent, prepare for, detect, and respond to outbreaks and other emergencies with health consequences. What changes in this renewed effort is a stronger push for consistent guidance and prioritization across activities, so that the collaboration aligns with a set of defined strategic objectives rather than being a collection of loosely connected projects.
Component 1 is guided by five strategic objectives that outline what the partnership is expected to accomplish at a global and country level. The first objective is to enhance global surveillance, early warning, and risk investigation and assessment, which points to improving the systems and analytical capacity needed to spot unusual events quickly and understand their potential impact. The second objective is to advance prevention and control of epidemic-prone diseases, covering the practical measures that reduce transmission and limit outbreaks, such as stronger public health guidance, preparedness planning, and support for proven control interventions. The third objective is to support countries in implementing the IHR (2005) Monitoring and Evaluation Framework (MEF) and developing National Action Plans, meaning the partnership is expected to help countries measure their readiness and translate assessment findings into concrete, funded, time-bound plans for improvement. The fourth objective is to strengthen country capacities to prevent, detect, and respond to emergencies and outbreaks, using MEF results as appropriate to target gaps and prioritize investments. The fifth objective is to coordinate and contribute to outbreak response and other health emergencies, reinforcing the expectation that the partnership will not only build capacity in calm periods, but also support real-time operations during crises.
Component 2, titled "Rapid Response to Highly Infectious Disease Outbreaks," is the surge capability side of the FOA. Its purpose is to expand CDC-WHO collaboration specifically for emergency outbreaks where rapid action is required on short notice. This component highlights operational readiness, including the ability to assure rapid detection and response and to support safe handling of patients or specimens suspected of infection with highly infectious agents. It also aims to strengthen WHO emergency preparedness and response capabilities more broadly, close urgent gaps in ongoing public health infrastructure and programs, and improve security and logistics support for local responders. In practice, this component is about being able to move quickly, protect responders and communities, and ensure that response operations are safe, coordinated, and effective when high-consequence pathogens or severe outbreaks arise.
From an administrative standpoint, the opportunity is a cooperative agreement, which typically means CDC anticipates substantial involvement in the work alongside the recipient rather than simply issuing a grant with minimal federal engagement. The CFDA listing is 93.318. The funding opportunity anticipated a single award (ExpectedAwards: 1). The posted award ceiling is listed as 0 in the source data, which usually indicates that the ceiling was not specified in the summary field or would be provided in the full announcement or budget guidance rather than in the abstract. The application window reflected an original posting date of April 24, 2019, with an original closing date of June 24, 2019, and electronic submissions due by 11:59 p.m. Eastern Time on the deadline date.
Eligibility is broadly referenced as "Others (see text field entitled Additional Information on Eligibility for clarification)," which, in the context of this FOA narrative, aligns with the intent to fund WHO as the core partner to carry out these activities through WHE and its networks. Overall, the opportunity is best understood as a continuation mechanism for a longstanding CDC-WHO partnership focused on IHR (2005) implementation, stronger surveillance and early warning, improved national preparedness and response capacity, and the ability to rapidly mobilize support during high-risk infectious disease events.Apply for CDC RFA GH19 1967
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthening Public Health Capacity and Guidelines to prevent, detect and control the spread of epidemic prone infectious diseases through Cooperation and Support from World Health Organization (WHO)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
- This funding opportunity was created on Apr 24, 2019.
- Applicants must submit their applications by Jun 24, 2019 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Funding Opportunity FAQs (CDC RFA GH19-1967)
What is CDC RFA GH19-1967?
CDC RFA GH19-1967 is a discretionary cooperative agreement funding opportunity from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Center for Global Health. It is intended to renew and extend a long-running CDC partnership with the World Health Organization (WHO) focused on emerging and epidemic-prone infectious diseases.
What is the main purpose of this cooperative agreement?
The purpose is to continue and formalize the next phase of CDC-WHO collaboration to help countries strengthen their ability to prevent, detect, assess, report, and respond to public health threats, consistent with the International Health Regulations (2005) (IHR 2005). The opportunity emphasizes practical country capacity building and coordinated outbreak readiness and response.
Which agencies and organizations are involved?
The funder is CDC (under HHS), specifically the CDC Center for Global Health. The central partner referenced throughout the opportunity is the World Health Organization (WHO), with work largely implemented through WHO programs housed within the WHO Health Emergencies Program (WHE).
Why is this funding opportunity being issued now (in the context provided)?
The announcement is designed to continue a five-year cooperative agreement that began September 1, 2015 and was scheduled to end August 31, 2019. It positions the new award as a continuation of a partnership that has operated through similar agreements since 1995, with clearer institutional direction and priorities in the renewed phase.
How does this opportunity connect to the 2011 U.S. Government-WHO Memorandum of Understanding (MOU)?
The opportunity is driven in part by the 2011 MOU between the U.S. Government and WHO, which focuses on supporting WHO Member States to meet IHR (2005) requirements. Activities under prior CDC-WHO agreements are described as already supporting these MOU goals by improving surveillance and response systems, strengthening national public health infrastructure, and providing technical assistance tied to global health security.
What is the International Health Regulations (2005) (IHR 2005) focus described in the opportunity?
IHR (2005) sets expectations for countries to build core capacities to detect, assess, report, and respond to public health threats that can cross borders. The opportunity emphasizes strengthening those capacities through surveillance, preparedness, monitoring and evaluation, national planning, and coordinated response.
What type of funding mechanism is this?
This is a cooperative agreement. Based on the description, CDC anticipates substantial involvement in the work alongside the recipient, rather than providing a grant with minimal federal engagement.
What is the CFDA number for this opportunity?
The CFDA listing provided is 93.318.
How many awards were anticipated?
The opportunity anticipated a single award (ExpectedAwards: 1).
Is there an award ceiling listed?
The posted award ceiling is listed as 0 in the source data. As described, that typically indicates the ceiling was not specified in the summary field and may instead be provided in the full announcement or detailed budget guidance, rather than in the abstract.
What were the key dates for posting and closing?
The opportunity shows an original posting date of April 24, 2019 and an original closing date of June 24, 2019.
When were applications due and what time zone applies?
Electronic submissions were due by 11:59 p.m. Eastern Time on the deadline date.
What are the main program components described?
The opportunity is structured around two main components: Component 1 (Core Activities) and Component 2 (Rapid Response to Highly Infectious Disease Outbreaks).
What is Component 1 (Core Activities)?
Component 1 covers the ongoing backbone of CDC and WHO collaboration, largely implemented through WHO programs now housed within the WHO Health Emergencies Program (WHE). It reflects decades of joint work to prevent, prepare for, detect, and respond to outbreaks and other emergencies with health consequences. In this renewed effort, there is an emphasis on stronger consistency, guidance, and prioritization so work aligns with defined strategic objectives rather than loosely connected projects.
What strategic objectives guide Component 1?
Component 1 is guided by five strategic objectives: (1) enhance global surveillance, early warning, and risk investigation and assessment; (2) advance prevention and control of epidemic-prone diseases; (3) support countries in implementing the IHR (2005) Monitoring and Evaluation Framework (MEF) and developing National Action Plans; (4) strengthen country capacities to prevent, detect, and respond to emergencies and outbreaks, using MEF results as appropriate; and (5) coordinate and contribute to outbreak response and other health emergencies.
What does "enhance global surveillance, early warning, and risk investigation and assessment" mean in this context?
In the context provided, it points to improving systems and analytical capacity to spot unusual events quickly and to understand their potential impact through timely investigation and assessment.
What does "advance prevention and control of epidemic-prone diseases" cover here?
As described, it includes practical measures that reduce transmission and limit outbreaks, such as stronger public health guidance, preparedness planning, and support for proven control interventions.
What is the IHR (2005) Monitoring and Evaluation Framework (MEF) role in this opportunity?
The partnership is expected to support countries in implementing the IHR (2005) MEF, including helping countries measure readiness and translate assessment findings into concrete National Action Plans that are described as concrete, funded, and time-bound plans for improvement.
How are National Action Plans referenced in the opportunity?
National Action Plans are described as an outcome of monitoring and evaluation efforts: countries use MEF results to create concrete plans that translate readiness assessments into prioritized improvements.
How does the opportunity describe strengthening country capacities?
It emphasizes strengthening capacities to prevent, detect, and respond to emergencies and outbreaks, using MEF results as appropriate to identify gaps and prioritize investments.
Does the opportunity focus only on preparedness, or also on real-time response?
It covers both. One of the Component 1 strategic objectives is to coordinate and contribute to outbreak response and other health emergencies, indicating expectations for real-time operational support during crises, in addition to capacity building between events.
What is Component 2 (Rapid Response to Highly Infectious Disease Outbreaks)?
Component 2 is the surge capability side of the opportunity. It is intended to expand CDC-WHO collaboration for emergency outbreaks where rapid action is required on short notice, with a focus on operational readiness and safe, coordinated response.
What activities or capabilities are highlighted under Component 2?
The description highlights the ability to assure rapid detection and response; support safe handling of patients or specimens suspected of infection with highly infectious agents; strengthen WHO emergency preparedness and response capabilities; close urgent gaps in ongoing public health infrastructure and programs; and improve security and logistics support for local responders.
What does "highly infectious disease outbreaks" imply in the description provided?
Based on the text, it refers to outbreaks involving high-consequence pathogens or severe outbreaks where rapid mobilization, responder safety, safe specimen or patient handling, and strong operational coordination are particularly critical.
How is WHO positioned within eligibility information provided?
Eligibility is referenced broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)." In the narrative context provided, it aligns with the intent to fund WHO as the core partner to carry out activities through WHE and its networks.
What is the overall mission or theme of the opportunity?
Overall, it is described as a continuation mechanism for the CDC-WHO partnership focused on IHR (2005) implementation, stronger surveillance and early warning, improved national preparedness and response capacity, and rapid mobilization support during high-risk infectious disease events.
How does this opportunity describe improvements compared to prior phases of collaboration?
While the collaboration has existed for decades, the renewed effort is described as providing clearer institutional direction and priorities, with a stronger push for consistent guidance and prioritization so activities align with defined strategic objectives rather than being loosely connected projects.
Browse more opportunities from the same category: Health
Next opportunity: DoD Prostate Cancer, Translational Science Award
Previous opportunity: Conservation Innovation Grants (CIG)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH19 1967
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH19 1967) also looked into and applied for these:
| Funding Opportunity |
|---|
| Rural Communities Opioid Response Program - Medication-Assisted Treatment Expansion (RCORP-MATE) Apply for HRSA 19 102 Funding Number: HRSA 19 102 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $725,000 |
| Rural Communities Opioid Response Program – Rural Centers of Excellence on Substance Use Disorders Apply for HRSA 19 108 Funding Number: HRSA 19 108 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $6,600,000 |
| Office of Urban Indian Health Programs 4-in-1 Grants, second opportunity Apply for HHS 2019 IHS UIHP2 0002 Funding Number: HHS 2019 IHS UIHP2 0002 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $578,561 |
| Urban Indian Education and Research Program Apply for HHS 2019 IHS UIHP3 0001 Funding Number: HHS 2019 IHS UIHP3 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $1,050,000 |
| Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health Apply for CDC RFA OT18 18020201SUPP19 Funding Number: CDC RFA OT18 18020201SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $10,000,000 |
| Emergency Department Surveillance of Nonfatal Suicide-Related Outcomes (ED-SNSRO) Apply for CDC RFA CE19 1906 Funding Number: CDC RFA CE19 1906 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $200,000 |
| Strengthening the Diagnostic Transport Network in Liberia Apply for CDC RFA GH19 1961 Funding Number: CDC RFA GH19 1961 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $2,000,000 |
| Strengthening Laboratory, Blood Safety, and Infection Prevention and Control Capacities in Liberia Apply for CDC RFA GH19 1962 Funding Number: CDC RFA GH19 1962 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
| National Harm Reduction Technical Assistance and Syringe Services Program (SSP) Monitoring and Evaluation Funding Opportunity Apply for CDC RFA PS19 1909 Funding Number: CDC RFA PS19 1909 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in Panama and Other Countries in the Americas Apply for RFA IP 20 001 Funding Number: RFA IP 20 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $1,000,000 |
| Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement Apply for CDC RFA OT18 18030201SUPP19 Funding Number: CDC RFA OT18 18030201SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $400,000 |
| Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity, and Security Apply for CDC RFA GH14 14180101SUPP19 Funding Number: CDC RFA GH14 14180101SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,000,000 |
| Drug-Free Communities (DFC) Support Program-Competing Continuation Apply for SP 19 006 Funding Number: SP 19 006 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $125,000 |
| Drug-Free Communities (DFC) Support Program-New Apply for SP 19 005 Funding Number: SP 19 005 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $125,000 |
| Technical Assistance for Response to Public Health or Healthcare Crises: OPIOID SUPPLEMENTAL Apply for CDC RFA OT18 18040101SUPP19 Funding Number: CDC RFA OT18 18040101SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: $3,500,000 |
| The Tuskegee Public Health Ethics Program Apply for CDC RFA PS20 2002 Funding Number: CDC RFA PS20 2002 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: $350,000 |
| Alliance for Innovation on Maternal Health (AIM) – Community Care Initiative Apply for HRSA 19 109 Funding Number: HRSA 19 109 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Rapid Response to Ebola Viral Disease in West Africa through Strengthening of Surveillance Systems and Disruption of Chain of Transmission Interventions Apply for CDC RFA GH15 16290401SUPP19 Funding Number: CDC RFA GH15 16290401SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $2,000,000 |
| American Indians into Medicine Apply for HHS 2019 IHS INMED 0001 Funding Number: HHS 2019 IHS INMED 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $195,000 |
| American Indians into Psychology Apply for HHS 2019 IHS INPSY 0001 Funding Number: HHS 2019 IHS INPSY 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $240,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH19 1967", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.